Author

T. Korontsvit

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Organism:human· 1

Frequent Co-Authors

D. A. Scheinberg· 2 shared T. Dao· 2 shared A. Charles· 1 shared A. Y. Chang· 1 shared C. A. Klebanoff· 1 shared C. Bourne· 1 shared C. Y. Oh· 1 shared H. F. Jones· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

D. A. Scheinberg

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivJun 18, 2020

Low-Dose CDK4/6 Inhibitors Induce Presentation of Pathway Specific MHC ligands as Targets for Cancer Immunotherapy

A. Charles, C. Bourne, S. S. Mun…·D. A. Scheinberg

This study shows low-dose CDK4/6 inhibitors increase HLA ligand presentation from cell cycle proteins, creating potential targets for immunotherapy in breast cancer.

DOI 10.1080/2162402x.2021.1916243

humanproteomics

𝕏 PostBluesky

Cancer BiologybioRxivSep 1, 2019

Identification of the targets of T cell receptor therapeutic agents and cells by use of a high throughput genetic platform

R. S. Gejman, H. F. Jones, M. G. Klatt…·D. A. Scheinberg

This study introduces a high-throughput genetic platform to identify on- and off-targets of T cell receptor therapeutic agents using MHC-I ligands.

DOI 10.1158/2326-6066.cir-19-0745

proteomicsexperimental assay

𝕏 PostBluesky